139 related articles for article (PubMed ID: 34987875)
1. A Case of Chorioretinitis with Retinal Angiomatous Proliferation.
Chen Y; Wei M; Chen Q; Li M
Case Rep Ophthalmol Med; 2021; 2021():3564939. PubMed ID: 34987875
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).
Konstantinidis L; Mameletzi E; Mantel I; Pournaras JA; Zografos L; Ambresin A
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1165-71. PubMed ID: 19404661
[TBL] [Abstract][Full Text] [Related]
3. [Intravitreal ranibizumab for the treatment of retinal angiomatous proliferation].
Maaß J; Sandner D; Matthé E
Ophthalmologe; 2017 Jun; 114(6):534-542. PubMed ID: 27743113
[TBL] [Abstract][Full Text] [Related]
4. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome.
Kim JM; Kim JH; Chang YS; Kim JW; Kim CG; Lee DW
Korean J Ophthalmol; 2017 Jun; 31(3):240-248. PubMed ID: 28471100
[TBL] [Abstract][Full Text] [Related]
6. Periocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment.
Zhang K; Chen Y; Sun X; Zhong Q; Lin L; Gao Y; Hong F
Medicine (Baltimore); 2018 Sep; 97(39):e12464. PubMed ID: 30278530
[TBL] [Abstract][Full Text] [Related]
7. Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation.
Saito M; Iida T; Kano M; Itagaki K
Clin Ophthalmol; 2012; 6():1385-91. PubMed ID: 22969283
[TBL] [Abstract][Full Text] [Related]
8. Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration.
Lai TY; Chan WM; Liu DT; Lam DS
Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1877-80. PubMed ID: 17901972
[TBL] [Abstract][Full Text] [Related]
9. Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation.
Cho HJ; Lee TG; Han SY; Kim HS; Kim JH; Han JI; Lew YJ; Kim JW
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):23-30. PubMed ID: 25825231
[TBL] [Abstract][Full Text] [Related]
10. Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angiomatous proliferation.
Boscia F; Furino C; Prascina F; Delle Noci N; Sborgia L; Sborgia C
Eur J Ophthalmol; 2005; 15(4):513-6. PubMed ID: 16001389
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.
Krieglstein TR; Kampik A; Ulbig M
Br J Ophthalmol; 2006 Nov; 90(11):1357-60. PubMed ID: 16885191
[TBL] [Abstract][Full Text] [Related]
12. Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
Nicolò M; Ghiglione D; Lai S; Calabria G
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1336-8. PubMed ID: 16523293
[TBL] [Abstract][Full Text] [Related]
13. Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
Saito M; Iida T; Kano M
Am J Ophthalmol; 2012 Mar; 153(3):504-514.e1. PubMed ID: 22078902
[TBL] [Abstract][Full Text] [Related]
14. Treatment of choroidal neovascularization using intravitreal bevacizumab.
Pedersen R; Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
[TBL] [Abstract][Full Text] [Related]
15. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.
Saito M; Shiragami C; Shiraga F; Nagayama D; Iida T
Am J Ophthalmol; 2008 Dec; 146(6):935-41.e1. PubMed ID: 18723139
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Aflibercept for Retinal Angiomatous Proliferation: Results of a Prospective Case Series at 96 Weeks.
Browning AC; O'Brien JM; Vieira RV; Gupta R; Nenova K
Ophthalmologica; 2019; 242(4):239-246. PubMed ID: 31163436
[TBL] [Abstract][Full Text] [Related]
17. Occlusive vasculitis due to hyperacute Streptococcus mitis endophthalmitis after intravitreal ranibizumab.
Baxter KR; Robinson JE; Ruby AJ
Retin Cases Brief Rep; 2015; 9(3):201-4. PubMed ID: 25764316
[TBL] [Abstract][Full Text] [Related]
18. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
Spielberg L; Leys A
Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
[TBL] [Abstract][Full Text] [Related]
19. Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Seidel G; Werner C; Weger M; Steinbrugger I; Haas A
Acta Ophthalmol; 2013 Sep; 91(6):e482-5. PubMed ID: 23786546
[TBL] [Abstract][Full Text] [Related]
20. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
Introini U; Torres Gimeno A; Scotti F; Setaccioli M; Giatsidis S; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
